barium sulphate (Varibar) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Barium sulfate, an insoluble in water substance, which was approved under the brand name E-Z-HD for use in double-contrast radiographic examinations of the esophagus, stomach and duodenum to visualize the gastrointestinal (GI) tract in patients 12 years and older. Due to its high atomic number, barium is opaque to x-rays and therefore acts as a positive contrast agent for radiographic studies.   NCATS

Chemistry

  • SMILES: [Ba++].[O-]S([O-])(=O)=O
  • InChIKey: TZCXTZWJZNENPQ-UHFFFAOYSA-L
  • Mol. Mass: 233.39
  • ALogP: Missing data
  • ChEMBL Molecule:
    barium sulfate  
More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Alternative names

baricon | barium sulfate | barium sulphate | barocat | barosperse | barosperse ii | barotrast | bar-test | epi-c | epi-stat 57 | epi-stat 61 | esophotrast | oratrast

Organizations (4)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (1)


 

Gastrointestinal Diseases (approved 2016)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Healthy Volunteers (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue